CIC
CVS icon

Carnegie Investment Counsel’s CVS Health CVS Stock Holding History

Carnegie Investment Counsel’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.94M Sell
38,104
-1,957
-5% -$175K 0.08% 186
2026
Q1 		$2.88M Sell
40,061
-8,634
-18% -$665K 0.06% 231
2025
Q4 		$3.86M Buy
+48,695
New +$3.84M 0.07% 201
2025
Q1 		– Sell
-5,283
Closed -$237K – 490
2024
Q4 		$237K Sell
5,283
-1,533
-22% -$86K 0.01% 424
2024
Q3 		$429K Sell
6,816
-422
-6% -$24.6K 0.01% 355
2024
Q2 		$427K Sell
7,238
-2,628
-27% -$164K 0.01% 357
2024
Q1 		$787K Sell
9,866
-17,319
-64% -$1.32M 0.02% 309
2023
Q4 		$2.15M Sell
27,185
-1,949
-7% -$139K 0.07% 197
2023
Q3 		$2.03M Sell
29,134
-31,715
-52% -$2.25M 0.08% 204
2023
Q2 		$4.21M Buy
60,849
+2,603
+4% +$185K 0.16% 144
2023
Q1 		$4.33M Buy
58,246
+2,606
+5% +$219K 0.17% 142
2022
Q4 		$5.19M Sell
55,640
-227
-0.4% -$21.9K 0.22% 117
2022
Q3 		$5.33M Buy
55,867
+12,527
+29% +$1.24M 0.25% 107
2022
Q2 		$4.02M Buy
43,340
+2,457
+6% +$240K 0.18% 130
2022
Q1 		$4.14M Buy
40,883
+3,196
+8% +$336K 0.15% 146
2021
Q4 		$3.89M Buy
37,687
+32,971
+699% +$3.05M 0.13% 159
2021
Q3 		$400K Hold
4,716
– – 0.02% 348
2021
Q2 		$394K Sell
4,716
-25
-0.5% -$2.05K 0.01% 351
2021
Q1 		$358K Sell
4,741
-490
-9% -$35.7K 0.02% 353
2020
Q4 		$357K Buy
5,231
+136
+3% +$8.85K 0.02% 337
2020
Q3 		$295K Hold
5,095
– – 0.02% 344
2020
Q2 		$327K Sell
5,095
-900
-15% -$56.7K 0.02% 334
2020
Q1 		$354K Sell
5,995
-3,879
-39% -$259K 0.02% 309
2019
Q4 		$734K Hold
9,874
– – 0.04% 256
2019
Q3 		$623K Buy
9,874
+721
+8% +$42.7K 0.04% 262
2019
Q2 		$499K Sell
9,153
-738
-7% -$39.7K 0.03% 309
2019
Q1 		$533K Sell
9,891
-12,212
-55% -$754K 0.04% 287
2018
Q4 		$1.45M Buy
22,103
+6,658
+43% +$497K 0.13% 161
2018
Q3 		$1.23M Sell
15,445
-17,913
-54% -$1.28M 0.1% 179
2018
Q2 		$2.28M Sell
33,358
-13,082
-28% -$862K 0.17% 134
2018
Q1 		$2.95M Buy
46,440
+5,132
+12% +$368K 0.25% 109
2017
Q4 		$3.03M Buy
41,308
+30,032
+266% +$2.18M 0.27% 111
2017
Q3 		$859K Sell
11,276
-11
-0.1% -$870 0.1% 192
2017
Q2 		$901K Sell
11,287
-4,277
-27% -$338K 0.11% 187
2017
Q1 		$1.26M Buy
15,564
+4,468
+40% +$357K 0.16% 151
2016
Q4 		$891K Buy
11,096
+87
+0.8% +$7.04K 0.12% 173
2016
Q3 		$965K Hold
11,009
– – 0.14% 155
2016
Q2 		$1.03M Sell
11,009
-457
-4% -$45.5K 0.14% 155
2016
Q1 		$1.18M Buy
11,466
+2,349
+26% +$228K 0.18% 136
2015
Q4 		$865K Sell
9,117
-1,052
-10% -$103K 0.15% 155
2015
Q3 		$1.07M Buy
10,169
+253
+3% +$26.6K 0.18% 134
2015
Q2 		$1.04M Hold
9,916
– – 0.18% 131
2015
Q1 		$1.01M Buy
9,916
+1,008
+11% +$102K 0.17% 133
2014
Q4 		$871K Buy
8,908
+4,898
+122% +$432K 0.16% 134
2014
Q3 		$319K Sell
4,010
-5,265
-57% -$415K 0.06% 225
2014
Q2 		$699K Buy
9,275
+6,443
+228% +$487K 0.16% 129
2014
Q1 		$212K Hold
2,832
– – 0.06% 204
2013
Q4 		$203K Sell
2,832
-788
-22% -$50.6K 0.05% 208
2013
Q3 		$205K Buy
+3,620
New +$216K 0.06% 198

Other funds holding CVS

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Carnegie Investment Counsel's CVS Position: Q2 2026 in Review

Carnegie Investment Counsel reduced its CVS Health (CVS) stake by 4.9% in Q2 2026, selling an estimated $175K and leaving 38,104 shares worth $3.94M. The position accounts for 0.08% of the portfolio, ranked #186.

Carnegie Investment Counsel first reported a position in CVS in Q3 2013 and has held it in 49 quarters since. The position peaked at $5.33M in Q3 2022. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Carnegie Investment Counsel held 38,104 shares of CVS Health worth $3.94M as of Q2 2026.
  • Carnegie Investment Counsel sold 1,957 CVS Health shares in Q2 2026, an estimated $175K.
  • CVS Health made up 0.08% of Carnegie Investment Counsel's portfolio in Q2 2026, its #186 holding.
  • Carnegie Investment Counsel first reported a position in CVS Health in Q3 2013 and has held it in 49 quarters since.
  • Carnegie Investment Counsel's CVS Health position peaked at $5.33M in Q3 2022.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.